Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients (Q44597660)

4 December 2017

title

Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients (English)

1 reference

4 December 2017

1 reference

6

1 reference

4 December 2017

3

Jordan W Smoller

1 reference

4 December 2017

5

A John Rush

1 reference

4 December 2017

1

Roy H Perlis

1 reference

4 December 2017

Gonzalo Laje

2

1 reference

4 December 2017

Maurizio Fava

series ordinal

4

1 reference

4 December 2017

language of work or name

English

0 references

publication date

18 March 2009

1 reference

4 December 2017

published in

Neuropsychopharmacology

1 reference

4 December 2017

volume

34

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

1819-1828

1 reference

Discontinuing or switching selective serotonin-reuptake inhibitors

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Sexual function and dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Preoptic glutamate facilitates male sexual behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Dopamine, the medial preoptic area, and male sexual behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Nitric oxide mediates glutamate-evoked dopamine release in the medial preoptic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Diagnosis and definition of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Role of glutamate receptors in the ventromedial hypothalamus in the regulation of female rat sexual behaviors. II. Behavioral effects of selective glutamate receptor antagonists AP-5, CNQX, and DNQX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Effect of lamotrigine on sexual function in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Hypersexuality in two patients with epilepsy treated with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Getting his act together: roles of glutamate, nitric oxide, and dopamine in the medial preoptic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Selective serotonin re-uptake inhibition attenuates evoked glutamate release in the dorsal horn of the anaesthetised rat in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Cumulative illness rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

The future of association studies: gene-based analysis and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Set association analysis of SNP case-control and microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

An NMDA antagonist impairs copulation and the experience-induced enhancement of male sexual behavior in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Spurious genetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

Mortality of patients with mood disorders: follow-up over 34-38 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Effect of excitatory amino acid, dopamine, and oxytocin receptor antagonists on noncontact penile erections and paraventricular nitric oxide production in male rats

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Physiological mechanisms of sexual dysfunction side effects associated with antidepressant medication

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Claims of Sex Differences

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

The Inventory of Depressive Symptomatology (IDS): psychometric properties.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2009.4

7 January 2021

Identifiers

DOI

10.1038/NPP.2009.4

1 reference

Dimensions Publication ID

4 December 2017

1015515596

0 references

1 reference